Withaferin A is a potent inhibitor of angiogenesis. - Wikidata - awgldk - TriplyDB

Withaferin A is a potent inhibitor of angiogenesis.

Withaferin A is a potent inhibitor of angiogenesis.

http://www.wikidata.org/entity/Q34363498

about

Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a model The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin A Decade of Molecular Understanding of Withanolide Biosynthesis and In vitro Studies in Withania somnifera (L.) Dunal: Prospects and Perspectives for Pathway Engineering Kinases as druggable targets in trypanosomatid protozoan parasites Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.Broad targeting of angiogenesis for cancer prevention and therapy Withaferin A disrupts ubiquitin-based NEMO reorganization induced by canonical NF-κB signaling Withania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transition A novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4 JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress Human iPSC-derived endothelial cell sprouting assay in synthetic hydrogel arrays Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies Withaferin a alters intermediate filament organization, cell shape and behavior Withaferin A inhibits the proteasome activity in mesothelioma in vitro and in vivo Water extract of Ashwagandha leaves has anticancer activity: identification of an active component and its mechanism of action Synthesis and mechanistic studies of a novel homoisoflavanone inhibitor of endothelial cell growth Withaferin a alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells Novel Methods to Generate Active Ingredients-Enriched Ashwagandha Leaves and Extracts A small molecule inhibitor of NFκB blocks ER stress and the NLRP3 inflammasome and prevents progression of pancreatitis.Real-time analysis of epithelial-mesenchymal transition using fluorescent single-domain antibodies Withaferin A Analogs That Target the AAA+ Chaperone p97.Anti-angiogenic effects of pterogynidine alkaloid isolated from Alchornea glandulosa.Switch in FOXA1 status associates with endometrial cancer progression Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.Withania somnifera targets interleukin-8 and cyclooxygenase-2 in human prostate cancer progression.Withaferin A targets intermediate filaments glial fibrillary acidic protein and vimentin in a model of retinal gliosis A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes.Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species.Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells.Withaferin A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancer Withaferin A induces proteasome inhibition, endoplasmic reticulum stress, the heat shock response and acquisition of thermotolerance.Targeting Notch Signaling in Colorectal Cancer.Tumor necrosis factor-α sensitizes breast cancer cells to natural products with proteasome-inhibitory activity leading to apoptosis Withaferin a strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity.Withaferin A effectively targets soluble vimentin in the glaucoma filtration surgical model of fibrosis.Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.Role of the cytoskeleton in formation and maintenance of angiogenic sprouts Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells

P2860

Q21143797-1D796740-C6A4-46E0-9547-76D1E3264FDC Q24633116-DF535730-E4C2-456B-97E5-C8FC05E1BB2D Q26774118-2F15AEA5-7893-4000-B482-93B9B104FD1B Q26786761-B27B9095-8B70-4B9B-9CA8-4BF15D373EFE Q26827810-BCDC9DF3-AFD5-489F-B0FD-451FAB3AE858 Q27002903-D87AD5FD-8A92-44CC-AFEE-8EAD43BE23D8 Q27302812-C0F07124-859D-45CC-8EEE-18A17EF6AF23 Q27305726-07739EA4-2F94-4480-A222-2FF37F80DC9B Q27321296-B1F8A1AD-07ED-41B6-9D84-546590B688DA Q28394074-C12AE841-31AA-41FF-982F-9ADD0F42B8F1 Q28397986-BBF85BC5-6A39-4532-AF8C-CED5A1D85F4F Q28473693-E382AA65-4351-445E-9EDD-33C2469B3096 Q28480441-62A0C89E-9A1D-4489-B9B5-68F54F3BA932 Q28482366-CB6A17BD-F4FD-4F75-9454-D81F66435711 Q28534335-6FEFBC79-6A40-4ECC-B7D7-CF880B0FA4A2 Q28538093-2C4079F6-29F6-4F61-AD11-AD68D487B542 Q28543359-C4EAA4CD-2C53-47BF-89DC-8420C1196EE8 Q28554871-8F047CE1-45B1-49B8-923D-538C25FB4B0C Q30276361-6946493A-9BA9-4B65-B034-5063F3C0391B Q30661925-99177BD6-9D79-4334-A1CD-6D360BC05238 Q33360763-0A39FCCE-42E1-48D3-80D6-8A76774646C3 Q33450973-7D36CCB9-9ADA-45C7-A63C-90C7715438DD Q33645463-D8B2D870-BDA2-4C00-9A82-8869AAF820B5 Q33690570-B442777A-B911-43DF-A263-D1E558E733D6 Q33739134-6B335AB7-BF54-4ADB-9346-2D75D27F727C Q33748201-F91EB731-839F-47CB-9FD4-E965FF186DC1 Q33755446-FDCFF065-34B5-4A58-9DBF-3BFE340C35E8 Q33766685-FAC62660-6D71-4D32-A3A4-735E03509684 Q33997100-D8C50DE0-F852-4680-99D3-D1E8D78419C2 Q34042070-32FCFD3F-A5E8-435D-9500-2A0DFE209E39 Q34253370-BD9F4315-3706-4A19-AE00-1A4FB5C21D02 Q34292101-05447677-04E3-438F-8ACA-76BE6E7E879D Q34316709-4C4E2212-E822-4C94-B620-C314E8D7B703 Q34482399-784DD192-9260-459F-B45D-CF21ECF568BF Q34566295-516E0C0A-C3DC-4DB6-B892-B3E88B4F32E0 Q34588342-B17C758C-C0B4-4B5C-BA4F-94D4C65CC942 Q34718470-077BB13A-D546-420D-9D01-77760C533371 Q34828174-DF65F182-0C05-4340-A122-38B4CC806AB6 Q34829230-6508B7D6-D1A9-4342-AE18-92B3DD41F619 Q34878214-6B2BE31D-E039-4DC2-8635-E582BA57E8F6

P2860

Withaferin A is a potent inhibitor of angiogenesis.

http://www.wikidata.org/entity/Q34363498

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Withaferin A is a potent inhibitor of angiogenesis.

@ast

Withaferin A is a potent inhibitor of angiogenesis.

@en

Withaferin A is a potent inhibitor of angiogenesis.

@nl

type

label

Withaferin A is a potent inhibitor of angiogenesis.

@ast

Withaferin A is a potent inhibitor of angiogenesis.

@en

Withaferin A is a potent inhibitor of angiogenesis.

@nl

prefLabel

Withaferin A is a potent inhibitor of angiogenesis.

@ast

Withaferin A is a potent inhibitor of angiogenesis.

@en

Withaferin A is a potent inhibitor of angiogenesis.

@nl

P1433

Q34363498-1A17CEB7-95C6-447C-9092-D42BC9981F41

P1476

Q34363498-0F228613-B015-44D5-9971-14C6F61E2CF3

P2093

Q34363498-3721272C-3E3B-4E75-BF1E-4759F7646F3E

Q34363498-3F08153A-83A1-42FF-8E12-DDCE65D04077

Q34363498-41ECB3A7-6802-4CA7-8FE3-5D7FB0413881

Q34363498-48FBEB0D-BD50-457D-9F3B-303E3F71B0D3

Q34363498-54B89D24-3BBA-4A50-8F3B-11841F076BD1

Q34363498-6EF9D186-7A10-451F-A2E1-32E431E29E50

Q34363498-87C65DE3-9444-4925-BF46-7A6B76E914D8

Q34363498-A3713E35-0179-41B9-A8C5-8DD620E8D048

Q34363498-D546261F-FFCF-47AE-8B7B-BDF844702B97

Q34363498-F6DFEB23-1926-44ED-938A-37E2B948F2E7

P2888

Q34363498-BBCC2A34-3F7A-46F1-B623-3AA8DA0AD435

P304

Q34363498-684EB57C-BF67-4443-BB89-342ECF207F45

P31

Q34363498-E462C07B-6473-4CB6-B1A6-1D1900817F63

P356

Q34363498-769AB20B-0401-404F-9452-C0212F2D8238

P433

Q34363498-08341C16-BC40-426D-A620-46D2BBDCF1F1

P478

Q34363498-FCD699A1-6DC2-4F79-8E4E-3CCE8C8D0F74

P577

Q34363498-E8A56684-D3CC-4E76-9CFA-65BB86921A18

P698

Q34363498-CDA6BEFC-A089-4281-A4A2-0D83DA9B87CB

P356

S10456-004-1026-3

P1433

P1476

Withaferin A is a potent inhibitor of angiogenesis.

@en

P2093

Antonio Ruiz

http://www.w3.org/2001/XMLSchema#string

Art D Hanson

http://www.w3.org/2001/XMLSchema#string

Barry P Conner

http://www.w3.org/2001/XMLSchema#string

Christopher J Herbstritt

http://www.w3.org/2001/XMLSchema#string

Hans J Hammers

http://www.w3.org/2001/XMLSchema#string

John Rougas

http://www.w3.org/2001/XMLSchema#string

Li Zhang

http://www.w3.org/2001/XMLSchema#string

Paola Bargagna-Mohan

http://www.w3.org/2001/XMLSchema#string

Royce Mohan

http://www.w3.org/2001/XMLSchema#string

Victor S Pribluda

http://www.w3.org/2001/XMLSchema#string

P2888

s10456-004-1026-3

P304

115-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10456-004-1026-3

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15516832

http://www.w3.org/2001/XMLSchema#string